Publication | Open Access
Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial
19
Citations
26
References
2022
Year
NCT02491983; https://clinicaltrials.gov/ct2/show/NCT02491983).
| Year | Citations | |
|---|---|---|
Page 1
Page 1